SITAGLIPTIN
SIVEM PHARMACEUTICALS ULC
Quick answers
Is there a shortage of SITAGLIPTIN in Canada?
No. There is no current shortage of SITAGLIPTIN 25MG reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
JANUVIA
MERCK CANADA INC
SANDOZ SITAGLIPTIN
SANDOZ CANADA INCORPORATED
PRO-SITAGLIPTIN
PRO DOC LIMITEE
Other Products
APO-SITAGLIPTIN
APOTEX INC
M-SITAGLIPTIN
MANTRA PHARMA INC
NAT-SITAGLIPTIN
NATCO PHARMA (CANADA) INC
⚠ Possible Recall or Safety Alert
Health Canada has issued a recall or safety alert matching this product. This match is based on product name similarity and may not be exact — confirm against your specific lot number before taking action.
DIN
02529033
Strength
25MG
Dosage Form
Tablet
Route
Oral
Active Ingredient
SITAGLIPTIN (SITAGLIPTIN PHOSPHATE MONOHYDRATE)
See all SITAGLIPTIN (SITAGLIPTIN PHOSPHATE MONOHYDRATE) products →Compare with another product →
Shortage History
No shortage or discontinuation reports on file for this product.
Other Products from SIVEM PHARMACEUTICALS ULC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
70MG · DIN 02299712
10MG · DIN 02447576
200MG · DIN 02385465
25MG · DIN 02451794
50MG · DIN 02451808
10MG · DIN 02451786
5MG · DIN 02385791
2.5MG · DIN 02385783
10MG · DIN 02385805
250MG · DIN 02401495
500MG · DIN 02401509
250MG · DIN 02401541